{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-013173","form_type":"8-K","ticker":"PLRX","cik":"0001746473","company_name":"PLIANT THERAPEUTICS, INC.","filed_at":"2023-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.393388+00:00","generated_at":"2026-06-20T11:54:01.567138+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"medium","headline":"Pliant Therapeutics launches underwritten public offering; terminates ATM prospectus","bullets":["Company commenced an underwritten public offering of common stock; terms not disclosed.","No shares were sold under prior $150M ATM facility from July 2021 to January 2023.","Existing Sales Agreement with Cantor Fitzgerald remains in effect but no sales until new prospectus filed.","Offering made via effective shelf registration statement (Form S-3)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-013173","json":"https://secwatch.observer/filing/0001193125-23-013173.json","markdown":"https://secwatch.observer/filing/0001193125-23-013173.md","text":"https://secwatch.observer/filing/0001193125-23-013173.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1746473/000119312523013173/0001193125-23-013173-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1746473/000119312523013173/d428465d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T11:54:01.567138+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}